1 recruiting. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Recruiting 1 |
Follow Neoplasms, Second Primary: new trials by email Literature Review of Neoplasms, Second Primary trials Research Report on Neoplasms, Second Primary
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM) Sacubitril-valsartan, Placebo - Breast Cancer, Neoplasm, Breast | Phase 4 | Recruiting | Silesian Centre for Heart Diseases | 600 | 2024-04-17 | 2025-03-14 |
Breast Diseases (1) · Breast Neoplasms (1) · Cardiotoxicity (1) · Heart Failure (1)
Cardiovascular Diseases (1) · Chemically-Induced Disorders (1) · Drug-Related Side Effects and Adverse Reactions (1) · Heart Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Radiation Injuries (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1) · Wounds and Injuries (1)
sacubitril and valsartan sodium hydrate drug combination (1)
Silesian Centre for Heart Diseases (1)
Poland (1)
Mateusz Tajstra (1)